Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
Article Category: Original Study
Publié en ligne: 09 août 2022
Pages: 333 - 338
Reçu: 03 janv. 2022
Accepté: 11 mai 2022
© 2022 Tomasz Jarzembowski et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.